世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

免疫サイトカインの世界市場インサイト、2030年までの予測


Global Immunocytokines Market Insights, Forecast to 2030

イムノサイトカイン(IC)は、腫瘍に反応するモノクローナル抗体を免疫細胞を活性化するサイトカインに結合させることによって作られる分子の一種である。 世界のイムノサイトカイン市場は、2024年の100万米ドル... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2024年8月15日 US$4,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

イムノサイトカイン(IC)は、腫瘍に反応するモノクローナル抗体を免疫細胞を活性化するサイトカインに結合させることによって作られる分子の一種である。
世界のイムノサイトカイン市場は、2024年の100万米ドルから2030年には100万米ドルへと、予測期間中の年平均成長率(CAGR)%で拡大すると予測されている。
米国とカナダの免疫サイトカイン市場は、2025年から2030年の予測期間中にCAGR%で、2024年の百万米ドルから2030年には百万米ドルに達すると予測されています。
免疫サイトカインの中国市場は、2024年の100万ドルから2030年には100万ドルに達すると推定され、2025年から2030年の予測期間中のCAGRは%である。
イムノサイトカインのヨーロッパ市場は、2024年の100万ドルから2030年には100万ドルに達すると推定され、2025年から2030年の予測期間中のCAGRは%である。
免疫細胞薬の世界の主要メーカーには、Alkermes Plc、AstraZeneca Plc、CytImmune、Cytune Pharma、Altor Biosciences Corporation、Apeiron Biologics AG、Paladin Labs、Teva Pharmaceutical Industries Ltd.、Valor Biotherapeuticsなどがある。2023年、世界の上位5社の売上高シェアは約 %であった。

レポートの対象
本レポートでは、イムノサイトカインの世界市場の概要、売上高、収益、価格を紹介しています。2019年~2023年の過去の市場収益/売上データ、2024年の予測、2030年までのCAGR予測による世界市場動向の分析。
免疫サイトカインの主要生産者を調査し、主要地域・国の売上高も掲載しています。免疫細胞薬の今後の市場ポテンシャルと、この市場を様々なセグメントとサブセグメントに分けて予測するための主要地域/国の注目点をハイライトしています。米国、カナダ、メキシコ、ブラジル、中国、日本、韓国、東南アジア、インド、ドイツ、英国、イタリア、中東、アフリカ、その他の国々の国別データと市場価値分析。

本レポートでは、2019年から2024年までのデータで、免疫サイトカインの売上高、収益、市場シェア、主要メーカーの業界ランキングに焦点を当てています。世界の免疫サイトカイン市場における主要なステークホルダーを特定し、その競争環境と市場ポジショニングを最近の動向とセグメント別の収益に基づいて分析します。本レポートは、利害関係者が競争環境を理解し、より多くの洞察を得て、より良い方法で事業と市場戦略を位置づけるのに役立ちます。
本レポートでは、2019年から2030年までのセグメントデータをタイプ別、用途別、売上高、収益、価格で分析しています。免疫サイトカインの売上高、予測成長動向、生産技術、用途、エンドユーザー産業の市場規模を評価・予測します。

市場区分
企業別
アルカーメス
アストラゼネカ
サイチューン
サイトューン・ファーマ
アルトール・バイオサイエンシズ株式会社
アペイロン・バイオロジクス
パラディン・ラボ
テバ・ファーマシューティカル・インダストリーズ
ヴァロー・バイオセラピューティクス
タルガ・セラピューティクス株式会社
イムノメディクス社
イムンジーン社
モルメッドS.p.A.
メルクKGaA
ネクター・セラピューティクス
ファイザー
F.ホフマン・ラ・ロシュ社
タイプ別セグメント
肝臓
視床下部
脂肪筋
BおよびTリンパ球
骨髄内皮
用途別セグメント
腫瘍および癌
関節リウマチ
地域別セグメント
米国およびカナダ
米国
カナダ
中国
アジア(中国を除く)
日本
韓国
中国 台湾
東南アジア
インド
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
ラテンアメリカ、中東、アフリカ
ブラジル
メキシコ
トルコ
イスラエル
GCC諸国

各章の概要
第1章:報告書のスコープ、各市場セグメント(タイプ別、用途別など)の市場規模、今後の発展可能性などのエグゼクティブサマリーを紹介。市場の現状と、短期・中期・長期的な展開の可能性について、ハイレベルな見解を提供しています。
第2章 世界、地域レベル、国レベルでの免疫サイトカインの販売(消費)、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展見通し、市場スペース、生産能力などを紹介しています。
第3章:免疫サイトカインメーカーの競争環境、価格、売上高、市場シェア、業界ランキング、最新の開発計画、M&A情報などを詳細に分析。
第4章:各種市場セグメントをタイプ別に分析し、各市場セグメントの売上高、収益、平均価格、発展可能性などを網羅し、読者が各市場セグメントのブルーオーシャン市場を見つけやすくします。
第5章:用途別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展可能性をカバーし、読者が異なる下流市場のブルーオーシャン市場を見つけるのを助ける。
第6章 北米(米国・カナダ):タイプ別、用途別、国別、セグメント別の売上高、収益。
第7章:ヨーロッパ:タイプ別、用途別、国別、セグメント別の売上高、収益。
第8章:中国:タイプ別、用途別、セグメント別の売上高、収益。
第9章:アジア(中国を除く):タイプ別、用途別、地域別、セグメント別の売上高、収益。
第10章:中東、アフリカ、中南米:タイプ別、用途別、国別、セグメント別の売上高、収益。
第11章:主要メーカーのプロファイルを提供し、製品の説明と仕様、免疫サイトカインの売上高、収益、価格、粗利益率、最近の開発など、市場の主要企業の基本的な状況を詳細に紹介する。
第12章:産業チェーン、販売チャネル、主要原材料、流通業者、顧客の分析。
第13章:市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界のメーカーが直面する課題とリスク、業界の関連政策の分析を紹介します。
第14章:レポートの要点と結論。


ページTOPに戻る


目次

1 Study Coverage
1.1 Immunocytokines Product Introduction
1.2 Market by Type
1.2.1 Global Immunocytokines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Liver
1.2.3 Hypothalamus
1.2.4 Fat muscle
1.2.5 B and T lymphocytes
1.2.6 Bone Marrow Endothelium
1.3 Market by Application
1.3.1 Global Immunocytokines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Tumors and Cancer
1.3.3 Rheumatoid Arthritis
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Immunocytokines Sales Estimates and Forecasts 2019-2030
2.2 Global Immunocytokines Revenue by Region
2.2.1 Global Immunocytokines Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Immunocytokines Revenue by Region (2019-2024)
2.2.3 Global Immunocytokines Revenue by Region (2025-2030)
2.2.4 Global Immunocytokines Revenue Market Share by Region (2019-2030)
2.3 Global Immunocytokines Sales Estimates and Forecasts 2019-2030
2.4 Global Immunocytokines Sales by Region
2.4.1 Global Immunocytokines Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Immunocytokines Sales by Region (2019-2024)
2.4.3 Global Immunocytokines Sales by Region (2025-2030)
2.4.4 Global Immunocytokines Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Immunocytokines Sales by Manufacturers
3.1.1 Global Immunocytokines Sales by Manufacturers (2019-2024)
3.1.2 Global Immunocytokines Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Immunocytokines in 2023
3.2 Global Immunocytokines Revenue by Manufacturers
3.2.1 Global Immunocytokines Revenue by Manufacturers (2019-2024)
3.2.2 Global Immunocytokines Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Immunocytokines Revenue in 2023
3.3 Global Key Players of Immunocytokines, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Immunocytokines Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Immunocytokines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Immunocytokines, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Immunocytokines, Product Offered and Application
3.8 Global Key Manufacturers of Immunocytokines, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Immunocytokines Sales by Type
4.1.1 Global Immunocytokines Historical Sales by Type (2019-2024)
4.1.2 Global Immunocytokines Forecasted Sales by Type (2025-2030)
4.1.3 Global Immunocytokines Sales Market Share by Type (2019-2030)
4.2 Global Immunocytokines Revenue by Type
4.2.1 Global Immunocytokines Historical Revenue by Type (2019-2024)
4.2.2 Global Immunocytokines Forecasted Revenue by Type (2025-2030)
4.2.3 Global Immunocytokines Revenue Market Share by Type (2019-2030)
4.3 Global Immunocytokines Price by Type
4.3.1 Global Immunocytokines Price by Type (2019-2024)
4.3.2 Global Immunocytokines Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Immunocytokines Sales by Application
5.1.1 Global Immunocytokines Historical Sales by Application (2019-2024)
5.1.2 Global Immunocytokines Forecasted Sales by Application (2025-2030)
5.1.3 Global Immunocytokines Sales Market Share by Application (2019-2030)
5.2 Global Immunocytokines Revenue by Application
5.2.1 Global Immunocytokines Historical Revenue by Application (2019-2024)
5.2.2 Global Immunocytokines Forecasted Revenue by Application (2025-2030)
5.2.3 Global Immunocytokines Revenue Market Share by Application (2019-2030)
5.3 Global Immunocytokines Price by Application
5.3.1 Global Immunocytokines Price by Application (2019-2024)
5.3.2 Global Immunocytokines Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Immunocytokines Market Size by Type
6.1.1 US & Canada Immunocytokines Sales by Type (2019-2030)
6.1.2 US & Canada Immunocytokines Revenue by Type (2019-2030)
6.2 US & Canada Immunocytokines Market Size by Application
6.2.1 US & Canada Immunocytokines Sales by Application (2019-2030)
6.2.2 US & Canada Immunocytokines Revenue by Application (2019-2030)
6.3 US & Canada Immunocytokines Market Size by Country
6.3.1 US & Canada Immunocytokines Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Immunocytokines Sales by Country (2019-2030)
6.3.3 US & Canada Immunocytokines Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Immunocytokines Market Size by Type
7.1.1 Europe Immunocytokines Sales by Type (2019-2030)
7.1.2 Europe Immunocytokines Revenue by Type (2019-2030)
7.2 Europe Immunocytokines Market Size by Application
7.2.1 Europe Immunocytokines Sales by Application (2019-2030)
7.2.2 Europe Immunocytokines Revenue by Application (2019-2030)
7.3 Europe Immunocytokines Market Size by Country
7.3.1 Europe Immunocytokines Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Immunocytokines Sales by Country (2019-2030)
7.3.3 Europe Immunocytokines Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Immunocytokines Market Size
8.1.1 China Immunocytokines Sales (2019-2030)
8.1.2 China Immunocytokines Revenue (2019-2030)
8.2 China Immunocytokines Market Size by Application
8.2.1 China Immunocytokines Sales by Application (2019-2030)
8.2.2 China Immunocytokines Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Immunocytokines Market Size by Type
9.1.1 Asia Immunocytokines Sales by Type (2019-2030)
9.1.2 Asia Immunocytokines Revenue by Type (2019-2030)
9.2 Asia Immunocytokines Market Size by Application
9.2.1 Asia Immunocytokines Sales by Application (2019-2030)
9.2.2 Asia Immunocytokines Revenue by Application (2019-2030)
9.3 Asia Immunocytokines Sales by Region
9.3.1 Asia Immunocytokines Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Immunocytokines Revenue by Region (2019-2030)
9.3.3 Asia Immunocytokines Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Immunocytokines Market Size by Type
10.1.1 Middle East, Africa and Latin America Immunocytokines Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Immunocytokines Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Immunocytokines Market Size by Application
10.2.1 Middle East, Africa and Latin America Immunocytokines Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Immunocytokines Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Immunocytokines Sales by Country
10.3.1 Middle East, Africa and Latin America Immunocytokines Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Immunocytokines Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Immunocytokines Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Alkermes Plc
11.1.1 Alkermes Plc Company Information
11.1.2 Alkermes Plc Overview
11.1.3 Alkermes Plc Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Alkermes Plc Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Alkermes Plc Recent Developments
11.2 AstraZeneca Plc
11.2.1 AstraZeneca Plc Company Information
11.2.2 AstraZeneca Plc Overview
11.2.3 AstraZeneca Plc Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 AstraZeneca Plc Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AstraZeneca Plc Recent Developments
11.3 CytImmune
11.3.1 CytImmune Company Information
11.3.2 CytImmune Overview
11.3.3 CytImmune Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 CytImmune Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 CytImmune Recent Developments
11.4 Cytune Pharma
11.4.1 Cytune Pharma Company Information
11.4.2 Cytune Pharma Overview
11.4.3 Cytune Pharma Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Cytune Pharma Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Cytune Pharma Recent Developments
11.5 Altor Biosciences Corporation
11.5.1 Altor Biosciences Corporation Company Information
11.5.2 Altor Biosciences Corporation Overview
11.5.3 Altor Biosciences Corporation Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Altor Biosciences Corporation Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Altor Biosciences Corporation Recent Developments
11.6 Apeiron Biologics AG
11.6.1 Apeiron Biologics AG Company Information
11.6.2 Apeiron Biologics AG Overview
11.6.3 Apeiron Biologics AG Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Apeiron Biologics AG Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Apeiron Biologics AG Recent Developments
11.7 Paladin Labs
11.7.1 Paladin Labs Company Information
11.7.2 Paladin Labs Overview
11.7.3 Paladin Labs Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Paladin Labs Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Paladin Labs Recent Developments
11.8 Teva Pharmaceutical Industries Ltd.
11.8.1 Teva Pharmaceutical Industries Ltd. Company Information
11.8.2 Teva Pharmaceutical Industries Ltd. Overview
11.8.3 Teva Pharmaceutical Industries Ltd. Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Teva Pharmaceutical Industries Ltd. Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Teva Pharmaceutical Industries Ltd. Recent Developments
11.9 Valor Biotherapeutics
11.9.1 Valor Biotherapeutics Company Information
11.9.2 Valor Biotherapeutics Overview
11.9.3 Valor Biotherapeutics Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Valor Biotherapeutics Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Valor Biotherapeutics Recent Developments
11.10 Targa Therapeutics Corporation
11.10.1 Targa Therapeutics Corporation Company Information
11.10.2 Targa Therapeutics Corporation Overview
11.10.3 Targa Therapeutics Corporation Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Targa Therapeutics Corporation Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Targa Therapeutics Corporation Recent Developments
11.11 Immunomedics, Inc.
11.11.1 Immunomedics, Inc. Company Information
11.11.2 Immunomedics, Inc. Overview
11.11.3 Immunomedics, Inc. Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Immunomedics, Inc. Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Immunomedics, Inc. Recent Developments
11.12 ImmunGene, Inc.
11.12.1 ImmunGene, Inc. Company Information
11.12.2 ImmunGene, Inc. Overview
11.12.3 ImmunGene, Inc. Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 ImmunGene, Inc. Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 ImmunGene, Inc. Recent Developments
11.13 MolMed S.p.A.
11.13.1 MolMed S.p.A. Company Information
11.13.2 MolMed S.p.A. Overview
11.13.3 MolMed S.p.A. Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024)
11.13.4 MolMed S.p.A. Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 MolMed S.p.A. Recent Developments
11.14 Merck KGaA
11.14.1 Merck KGaA Company Information
11.14.2 Merck KGaA Overview
11.14.3 Merck KGaA Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024)
11.14.4 Merck KGaA Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Merck KGaA Recent Developments
11.15 Nektar Therapeutics
11.15.1 Nektar Therapeutics Company Information
11.15.2 Nektar Therapeutics Overview
11.15.3 Nektar Therapeutics Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024)
11.15.4 Nektar Therapeutics Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Nektar Therapeutics Recent Developments
11.16 Pfizer, Inc.
11.16.1 Pfizer, Inc. Company Information
11.16.2 Pfizer, Inc. Overview
11.16.3 Pfizer, Inc. Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024)
11.16.4 Pfizer, Inc. Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Pfizer, Inc. Recent Developments
11.17 F. Hoffmann-La Roche, Ltd.
11.17.1 F. Hoffmann-La Roche, Ltd. Company Information
11.17.2 F. Hoffmann-La Roche, Ltd. Overview
11.17.3 F. Hoffmann-La Roche, Ltd. Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024)
11.17.4 F. Hoffmann-La Roche, Ltd. Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 F. Hoffmann-La Roche, Ltd. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Immunocytokines Industry Chain Analysis
12.2 Immunocytokines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Immunocytokines Production Mode & Process
12.4 Immunocytokines Sales and Marketing
12.4.1 Immunocytokines Sales Channels
12.4.2 Immunocytokines Distributors
12.5 Immunocytokines Customers
13 Market Dynamics
13.1 Immunocytokines Industry Trends
13.2 Immunocytokines Market Drivers
13.3 Immunocytokines Market Challenges
13.4 Immunocytokines Market Restraints
14 Key Findings in The Global Immunocytokines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

 

ページTOPに戻る


 

Summary

Immunocytokines (ICs) are a class of molecules created by linking tumor-reactive monoclonal antibodies to cytokines that are able to activate immune cells.
The global Immunocytokines market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Immunocytokines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Immunocytokines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Immunocytokines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Immunocytokines include Alkermes Plc, AstraZeneca Plc, CytImmune, Cytune Pharma, Altor Biosciences Corporation, Apeiron Biologics AG, Paladin Labs, Teva Pharmaceutical Industries Ltd. and Valor Biotherapeutics, etc. In 2023, the global top five players had a share approximately % in terms of revenue.

Report Covers:
This report presents an overview of global market for Immunocytokines, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Immunocytokines, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Immunocytokines, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Immunocytokines sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Immunocytokines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Immunocytokines sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation
By Company
Alkermes Plc
AstraZeneca Plc
CytImmune
Cytune Pharma
Altor Biosciences Corporation
Apeiron Biologics AG
Paladin Labs
Teva Pharmaceutical Industries Ltd.
Valor Biotherapeutics
Targa Therapeutics Corporation
Immunomedics, Inc.
ImmunGene, Inc.
MolMed S.p.A.
Merck KGaA
Nektar Therapeutics
Pfizer, Inc.
F. Hoffmann-La Roche, Ltd.
Segment by Type
Liver
Hypothalamus
Fat muscle
B and T lymphocytes
Bone Marrow Endothelium
Segment by Application
Tumors and Cancer
Rheumatoid Arthritis
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Immunocytokines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Immunocytokines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Immunocytokines sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.



ページTOPに戻る


Table of Contents

1 Study Coverage
1.1 Immunocytokines Product Introduction
1.2 Market by Type
1.2.1 Global Immunocytokines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Liver
1.2.3 Hypothalamus
1.2.4 Fat muscle
1.2.5 B and T lymphocytes
1.2.6 Bone Marrow Endothelium
1.3 Market by Application
1.3.1 Global Immunocytokines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Tumors and Cancer
1.3.3 Rheumatoid Arthritis
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Immunocytokines Sales Estimates and Forecasts 2019-2030
2.2 Global Immunocytokines Revenue by Region
2.2.1 Global Immunocytokines Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Immunocytokines Revenue by Region (2019-2024)
2.2.3 Global Immunocytokines Revenue by Region (2025-2030)
2.2.4 Global Immunocytokines Revenue Market Share by Region (2019-2030)
2.3 Global Immunocytokines Sales Estimates and Forecasts 2019-2030
2.4 Global Immunocytokines Sales by Region
2.4.1 Global Immunocytokines Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Immunocytokines Sales by Region (2019-2024)
2.4.3 Global Immunocytokines Sales by Region (2025-2030)
2.4.4 Global Immunocytokines Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Immunocytokines Sales by Manufacturers
3.1.1 Global Immunocytokines Sales by Manufacturers (2019-2024)
3.1.2 Global Immunocytokines Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Immunocytokines in 2023
3.2 Global Immunocytokines Revenue by Manufacturers
3.2.1 Global Immunocytokines Revenue by Manufacturers (2019-2024)
3.2.2 Global Immunocytokines Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Immunocytokines Revenue in 2023
3.3 Global Key Players of Immunocytokines, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Immunocytokines Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Immunocytokines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Immunocytokines, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Immunocytokines, Product Offered and Application
3.8 Global Key Manufacturers of Immunocytokines, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Immunocytokines Sales by Type
4.1.1 Global Immunocytokines Historical Sales by Type (2019-2024)
4.1.2 Global Immunocytokines Forecasted Sales by Type (2025-2030)
4.1.3 Global Immunocytokines Sales Market Share by Type (2019-2030)
4.2 Global Immunocytokines Revenue by Type
4.2.1 Global Immunocytokines Historical Revenue by Type (2019-2024)
4.2.2 Global Immunocytokines Forecasted Revenue by Type (2025-2030)
4.2.3 Global Immunocytokines Revenue Market Share by Type (2019-2030)
4.3 Global Immunocytokines Price by Type
4.3.1 Global Immunocytokines Price by Type (2019-2024)
4.3.2 Global Immunocytokines Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Immunocytokines Sales by Application
5.1.1 Global Immunocytokines Historical Sales by Application (2019-2024)
5.1.2 Global Immunocytokines Forecasted Sales by Application (2025-2030)
5.1.3 Global Immunocytokines Sales Market Share by Application (2019-2030)
5.2 Global Immunocytokines Revenue by Application
5.2.1 Global Immunocytokines Historical Revenue by Application (2019-2024)
5.2.2 Global Immunocytokines Forecasted Revenue by Application (2025-2030)
5.2.3 Global Immunocytokines Revenue Market Share by Application (2019-2030)
5.3 Global Immunocytokines Price by Application
5.3.1 Global Immunocytokines Price by Application (2019-2024)
5.3.2 Global Immunocytokines Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Immunocytokines Market Size by Type
6.1.1 US & Canada Immunocytokines Sales by Type (2019-2030)
6.1.2 US & Canada Immunocytokines Revenue by Type (2019-2030)
6.2 US & Canada Immunocytokines Market Size by Application
6.2.1 US & Canada Immunocytokines Sales by Application (2019-2030)
6.2.2 US & Canada Immunocytokines Revenue by Application (2019-2030)
6.3 US & Canada Immunocytokines Market Size by Country
6.3.1 US & Canada Immunocytokines Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Immunocytokines Sales by Country (2019-2030)
6.3.3 US & Canada Immunocytokines Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Immunocytokines Market Size by Type
7.1.1 Europe Immunocytokines Sales by Type (2019-2030)
7.1.2 Europe Immunocytokines Revenue by Type (2019-2030)
7.2 Europe Immunocytokines Market Size by Application
7.2.1 Europe Immunocytokines Sales by Application (2019-2030)
7.2.2 Europe Immunocytokines Revenue by Application (2019-2030)
7.3 Europe Immunocytokines Market Size by Country
7.3.1 Europe Immunocytokines Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Immunocytokines Sales by Country (2019-2030)
7.3.3 Europe Immunocytokines Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Immunocytokines Market Size
8.1.1 China Immunocytokines Sales (2019-2030)
8.1.2 China Immunocytokines Revenue (2019-2030)
8.2 China Immunocytokines Market Size by Application
8.2.1 China Immunocytokines Sales by Application (2019-2030)
8.2.2 China Immunocytokines Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Immunocytokines Market Size by Type
9.1.1 Asia Immunocytokines Sales by Type (2019-2030)
9.1.2 Asia Immunocytokines Revenue by Type (2019-2030)
9.2 Asia Immunocytokines Market Size by Application
9.2.1 Asia Immunocytokines Sales by Application (2019-2030)
9.2.2 Asia Immunocytokines Revenue by Application (2019-2030)
9.3 Asia Immunocytokines Sales by Region
9.3.1 Asia Immunocytokines Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Immunocytokines Revenue by Region (2019-2030)
9.3.3 Asia Immunocytokines Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Immunocytokines Market Size by Type
10.1.1 Middle East, Africa and Latin America Immunocytokines Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Immunocytokines Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Immunocytokines Market Size by Application
10.2.1 Middle East, Africa and Latin America Immunocytokines Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Immunocytokines Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Immunocytokines Sales by Country
10.3.1 Middle East, Africa and Latin America Immunocytokines Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Immunocytokines Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Immunocytokines Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Alkermes Plc
11.1.1 Alkermes Plc Company Information
11.1.2 Alkermes Plc Overview
11.1.3 Alkermes Plc Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Alkermes Plc Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Alkermes Plc Recent Developments
11.2 AstraZeneca Plc
11.2.1 AstraZeneca Plc Company Information
11.2.2 AstraZeneca Plc Overview
11.2.3 AstraZeneca Plc Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 AstraZeneca Plc Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AstraZeneca Plc Recent Developments
11.3 CytImmune
11.3.1 CytImmune Company Information
11.3.2 CytImmune Overview
11.3.3 CytImmune Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 CytImmune Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 CytImmune Recent Developments
11.4 Cytune Pharma
11.4.1 Cytune Pharma Company Information
11.4.2 Cytune Pharma Overview
11.4.3 Cytune Pharma Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Cytune Pharma Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Cytune Pharma Recent Developments
11.5 Altor Biosciences Corporation
11.5.1 Altor Biosciences Corporation Company Information
11.5.2 Altor Biosciences Corporation Overview
11.5.3 Altor Biosciences Corporation Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Altor Biosciences Corporation Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Altor Biosciences Corporation Recent Developments
11.6 Apeiron Biologics AG
11.6.1 Apeiron Biologics AG Company Information
11.6.2 Apeiron Biologics AG Overview
11.6.3 Apeiron Biologics AG Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Apeiron Biologics AG Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Apeiron Biologics AG Recent Developments
11.7 Paladin Labs
11.7.1 Paladin Labs Company Information
11.7.2 Paladin Labs Overview
11.7.3 Paladin Labs Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Paladin Labs Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Paladin Labs Recent Developments
11.8 Teva Pharmaceutical Industries Ltd.
11.8.1 Teva Pharmaceutical Industries Ltd. Company Information
11.8.2 Teva Pharmaceutical Industries Ltd. Overview
11.8.3 Teva Pharmaceutical Industries Ltd. Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Teva Pharmaceutical Industries Ltd. Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Teva Pharmaceutical Industries Ltd. Recent Developments
11.9 Valor Biotherapeutics
11.9.1 Valor Biotherapeutics Company Information
11.9.2 Valor Biotherapeutics Overview
11.9.3 Valor Biotherapeutics Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Valor Biotherapeutics Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Valor Biotherapeutics Recent Developments
11.10 Targa Therapeutics Corporation
11.10.1 Targa Therapeutics Corporation Company Information
11.10.2 Targa Therapeutics Corporation Overview
11.10.3 Targa Therapeutics Corporation Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Targa Therapeutics Corporation Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Targa Therapeutics Corporation Recent Developments
11.11 Immunomedics, Inc.
11.11.1 Immunomedics, Inc. Company Information
11.11.2 Immunomedics, Inc. Overview
11.11.3 Immunomedics, Inc. Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Immunomedics, Inc. Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Immunomedics, Inc. Recent Developments
11.12 ImmunGene, Inc.
11.12.1 ImmunGene, Inc. Company Information
11.12.2 ImmunGene, Inc. Overview
11.12.3 ImmunGene, Inc. Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 ImmunGene, Inc. Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 ImmunGene, Inc. Recent Developments
11.13 MolMed S.p.A.
11.13.1 MolMed S.p.A. Company Information
11.13.2 MolMed S.p.A. Overview
11.13.3 MolMed S.p.A. Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024)
11.13.4 MolMed S.p.A. Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 MolMed S.p.A. Recent Developments
11.14 Merck KGaA
11.14.1 Merck KGaA Company Information
11.14.2 Merck KGaA Overview
11.14.3 Merck KGaA Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024)
11.14.4 Merck KGaA Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Merck KGaA Recent Developments
11.15 Nektar Therapeutics
11.15.1 Nektar Therapeutics Company Information
11.15.2 Nektar Therapeutics Overview
11.15.3 Nektar Therapeutics Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024)
11.15.4 Nektar Therapeutics Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Nektar Therapeutics Recent Developments
11.16 Pfizer, Inc.
11.16.1 Pfizer, Inc. Company Information
11.16.2 Pfizer, Inc. Overview
11.16.3 Pfizer, Inc. Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024)
11.16.4 Pfizer, Inc. Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Pfizer, Inc. Recent Developments
11.17 F. Hoffmann-La Roche, Ltd.
11.17.1 F. Hoffmann-La Roche, Ltd. Company Information
11.17.2 F. Hoffmann-La Roche, Ltd. Overview
11.17.3 F. Hoffmann-La Roche, Ltd. Immunocytokines Sales, Price, Revenue and Gross Margin (2019-2024)
11.17.4 F. Hoffmann-La Roche, Ltd. Immunocytokines Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 F. Hoffmann-La Roche, Ltd. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Immunocytokines Industry Chain Analysis
12.2 Immunocytokines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Immunocytokines Production Mode & Process
12.4 Immunocytokines Sales and Marketing
12.4.1 Immunocytokines Sales Channels
12.4.2 Immunocytokines Distributors
12.5 Immunocytokines Customers
13 Market Dynamics
13.1 Immunocytokines Industry Trends
13.2 Immunocytokines Market Drivers
13.3 Immunocytokines Market Challenges
13.4 Immunocytokines Market Restraints
14 Key Findings in The Global Immunocytokines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同じKEY WORD()の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/21 10:26

156.13 円

165.08 円

200.38 円

ページTOPに戻る